TMCnet News
Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022SAN DIEGO, Calif. and GAINESVILLE, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the second quarter 2022 after the market close on Wednesday, August 10, 2022. Societal’s management team will host a webcast at 4:30 p.m. ET on Wednesday, August 10, 2022, to discuss the financial results and recent operational highlights. A live webcast can be accessed by visiting the “Investor Events” page in the Investor section of the company’s website: https://ir.societalcdmo.com/events. In adition, an archived webcast will be available on the company’s website approximately two hours after the event and will be available for 30 days. About Societal CDMO In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California. Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com. Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 [email protected] Tim Brons (Media) Vida Strategic Partners 415-675-7402 [email protected] Ryan D. Lake (CFO) Societal CDMO 770-531-8365 [email protected] |